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Abstract 
 
Background: Few studies have addressed the secular trend of malignancies in developing countries such as 
Iran. This study aimed to determine the trend in the incidence of gastrointestinal cancers during a period of 15 
years in Kermanshah, Iran. 
 
Methods:  All of the confirmed positive pathologic reports for esophageal, gastric and colorectal cancers from 
1993 to 2007 were collected and compared with the data compiled in the provincial health center. The incidence 
rate was standardized for world population using a direct method. The Fay and Feuer method was used to calcu-
late the 95% confidence intervals for each cancer in each year. Trends were investigated using linear regression. 
 
Results: Over the period, 2951 cases of gastrointestinal cancer were reported in Kermanshah Province. The 
age-standardized incidence rates for gastric, esophageal and colorectal cancers were 9.2, 8.1 and 4.5 per 
100,000 respectively over 15 years. In all types, the incidence increased with age. The study showed that the 
incidence of gastric and esophageal cancers decreased annually by 0.28 (-0.67-0.11) and 0.36 (-0.70 – (-0.02)), 
respectively. Colorectal cancer demonstrated an increase in the incidence [0.14 (95% CI: -0.01-0.29) annually].  
 
Conclusion: A decrease in the incidence of gastric and esophageal cancers and an increase in the incidence of 
colorectal cancer are in line with reports from other developing countries in epidemiologic transition. Such trends 
warrant in depth investigation for the exact reasons. 
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Introduction 
 
Cancer is the leading cause of mortality in both de-
veloped and developing countries. Annually, it causes 
around seven million deaths (about 13% of all causes 
of death) in the world and is the second most com-
mon cause of death in developed countries and 
among the top three causes of adult death in develop-
ing countries.
1 Despite the predicted decrease in can-
cer related mortality rate by 2020, the number of can-
cer related deaths does not seem to decrease in future 
and it is estimated that the figure will even rise in 
2020.
2 The major part of such rise occurs in develop-
ing counties where 70% of cancer related deaths will 
occur.
3 The highest number of cancer related deaths 
belongs to lung cancer (1.3 million deaths per year), 
gastric cancer (803000/year), colorectal cancer 
(639,000/year), liver cancer (610,000/year) and breast 
cancer (519,000). The epidemiologic pattern of can-
cer varies by sex; while for men, the most common 
cancers are lung, stomach, liver, colorectal, esopha-
gus and prostate and in women are breast, lung, stom-
ach, colorectal and cervical cancers.
4 Age-specific 
rate (ASR) in males in Fars Province for cancer of 
esophagus, stomach, small intestine, colon-rectum 
and liver was 1.05, 3.82, 0.15, 3.26 and 0.29 and the-
se figures in females was 0.87, 1.60, 0.13, 2.41 and 
0.42.
5 In southeastern Iran in Zahedan, for esophageal 
cancer, a higher prevalence of esophageal cancer was 
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noticed in females, age group of older than 60 years 
and smokers and a most common type of squamous 
cell carcinoma.
6  
Such increase in number of cancers has many rea-
sons. Undoubtedly, the increase in the number of new 
cases of cancer is due to the change in overall pattern 
of occurrence of diseases around the world. In other 
words, developing countries are experiencing an epi-
demiological transition period that is characterized by 
a gradual decrease in death due to communicable dis-
eases and a parallel increase in death due to chronic 
conditions.
4 The major factors contributing to such 
changes are aging, life style change toward unhealthi-
er patterns, decrease in incidence of infectious diseas-
es and appropriate diagnosis and treatment of both 
communicable and non-communicable illnesses. 
Among all cancers, malignancies of gastrointesti-
nal tract are the most important ones in terms of a 
broad spectrum of cancers and overall incidence. 
While the middle East, including Iran, is considered 
as a low risk region for colorectal cancer, but gastric 
and esophageal cancers are still common dangers in 
some parts of Iran.
7 Considering the potential differ-
ence in the prevalence of risk factors of gastrointesti-
nal malignancies in different provinces of Iran from 
one hand and recent improvement in health care ser-
vices on the other, a study of secular trend in inci-
dence of such malignancies could present a clear fig-
ure in epidemiology of gastrointestinal cancers over 
recent years. In absence of standard population-based 
cancer registries in most areas of Iran,
8  attempts to 
demonstrate the true incidence of cancer in different 
areas were mostly unsuccessful.
7,9-13 Yet, most studies 
have either not addressed the secular trend or not 
matched the rates to a standard population and are 
hence not comparable with international statistics.
9-11 
In addition, there is no published report on trends in 
incidence of gastrointestinal cancers in Kemanshah 
Province (Western Iran). We aimed to provide a clear 
comparable figure of trends in incidence of gastroin-
testinal tract malignancies in Kermanshah Province, 
Western Iran. 
 
 
Materials and Methods 
 
Kermanshah, the largest Province in the western part 
of Iran, is neighbor to Iraq. The estimated population 
of the province is around 2,000,000 people. Kerman-
shah has a pathology-based cancer registry system 
established in 2001. Upon approval from Ethics 
Committee of Kermanshah University of Medical 
Sciences and for the purpose of this study, all positive 
pathologic reports for a gastrointestinal cancer from 
1993 to 2007 were included. The reports collected 
during 2001-2007 were compared with the computer-
ized records of registered cancers and deaths filed in 
the statistical unit of the provincial health center. The 
registered cancers were coded using ICD-10. Esopha-
geal, gastric and colorectal cancers were defined by 
C15, C16 and C18-C20, respectively. For every year 
that the data were available in the provincial registry, 
the registered cases were compared with pathologic 
reports and in case of a mismatch, the new cases were 
included. Data were then sorted by name, father’s 
name and age. All repeated cases were excluded. In 
addition, according to the address provided in pathol-
ogy reports, the referred cases from neighboring 
provinces were excluded. 
Descriptive statistics was used to fulfill the objec-
tives of the study. STATA software (version 8) was 
implemented to determine the secular trend and other 
analyses. Age specific incidence rates were calculated 
for each cancer in each year by dividing the number 
of cancers diagnosed in each year by the population 
of Kermanshah at the same year. The population of 
Kermanshah was extracted from Statistical Center of 
Iran.
14 The population was divided into six age 
groups (0-39, 40-49, 50-59, 60-69, 70-79, ≥80 years). 
Age- standardized incidence rates were calculated 
using the World Standard Population.
15 Incidence rate 
was standardized using the direct method. The Fay 
and Feuer method was used to calculate the 95% con-
fidence interval for standardized incidence rates.
16 The 
changes in the annual incidence of the cancers under 
study were calculated using simple linear regression.  
 
 
Results 
 
A total of 1232 cases (336 women and 896 men) of 
gastric cancer were reported during the 15 years peri-
od of study in Kermanshah Province. The incidence 
was at a peak of 112 cases in 2007. Overall, the inci-
dence of gastric cancer increased with age so that the 
age group ≥80 showed 3.2 times higher incidence 
than those in group 60-69 years. The standardized 
incidence during the 15-year period showed great 
fluctuations but overall, there was a decreasing trend 
from 10.6/100,000 (95%CI: 8.2-13.9) in 1993 to 
9.1/100,000 (95%CI: 7.4-11.1) in 2007 (Table 1). The 
average decrease in the annual incidence of gastric Gastrointestinal tract cancers 
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cancer was 0.28 per 100,000 (95%CI: -0.67-(0.11)). 
The incidence was higher in men and the male to fe-
male ratio varied between 1.1 and 6.0. Overall, the 
standardized incidence rate of gastric cancer was 9.2 
in 100,000.  
Between 1993 and 2007, there were 1048 cases of 
reported esophageal cancer in Kermanshah Province 
of which 51% were men. As evidenced by the data, 
for most years, the incidence of this type of cancer 
increased with age (Table 2). Like gastric cancer, the 
incidence of esophageal cancer decreased during the 
period. The incidence decreased from 10, 7/100,000 
(95%CI: 8.3-13.9) in 1993 to 5.0/100,000 (95%CI: 
3.8-6.5) in 2007 (Table 2). The drop in the annual 
incidence of this cancer in Kermanshah Province was 
-0.36 per 100,000 (95%CI:-0.70 – (-0.02)). The 
standardized incidence rate of esophageal cancer was 
8.1 per 100,000 over 15 years. 
Among 665 cases of colorectal cancer reported 
during 1993 to 2007, 394 cases (59%) were men. 
More than half of the cases were reported between 
2002 and 2007. Like gastric and esophageal cancers, 
the incidence of colorectal cancer increased with age 
in both genders (Table 3). Peak incidence rate for 
Table 1: Age-specific and -standardized rate/100,000
a of stomach cancer in Kermanshah Province 
  1993  1994 1995  1996 1997 1998  1999  2000 2001  2002 2003 2004 2005 2006 2007 
0-39  0.3  0.1 0.1  0.3 0.1 0.0  0.4  0.1 0.1  0.2 0.3 0.3 0.3 0.4 0.2 
40-49  1.0  5.0 2.6  3.1 4.8 3.3  4.1  0.7 5.7  6.6 3.1 7.8 4.9 2.5 7.2 
50-59  13.1  17.7 7.1  13.7 5.7  9.0  6.4  10.4 6.6  9.6  15.4 21.6 16.1 26.6 23.4 
60-69  50.6  59.2 29.7  54.3 34.1 16.1  32.7  29.5 19.5  33.2 51.6 54.3 45.3 34.0 40.7 
70-79 38.2  40.8  29.3  58.6  46.3  27.7  64.2  54.5  39.3  50.5  111.5 150.8 159.5 166.4 172.0 
>80  28.6  63.8  53.2  124.5 267.9 22.1  30.3  230.9 86.0  215.4 213.6 239.5 258.5 297.8 272.6 
Age 
95% 
CI 
10.6 
(8.2  - 
13.9) 
13.8 
(11.0  - 
17.4) 
8.3 
(6.0  - 
11.4) 
15.8 
(12.6 
-19.7) 
15.5 
(12.1  - 
19.6) 
5.1 
(3.6 
-7.2) 
6.7 
(5.1-
9.0) 
8.7 
(6.5-
11.6) 
7.3 
(4.9  - 
10.7) 
6.7 
(5.1-
8.7) 
8.5 
(6.8-
10.6) 
10.0 
(8.2-
12.1) 
8.7 
(7.1  - 
10.8) 
9.1 
(7.4  - 
11.1) 
9.1 
(7.4  - 
11.0) 
a Rates have been standardized with world standard population 
Table 2: Age-specific and -standardized rate/100,000
a of esophageal cancer in Kermanshah Province. 
Age 
(Year) 
1993 1994  1995  1996 1997 1998  1999  2000 2001 2002 2003 2004 2005 2006 2007 
0-39  0.0 0.1  0.0  0.1 0.1 0.1  0.4  0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 
40-49  2.9 4.0  2.1  5.2 2.6 1.1  2.7  0.7 5.7 3.7 7.6 6.2 4.0 2.5 1.8 
50-59  12.3 18.6  10.7  20.9 8.5  5.0  11.5  11.7 9.3  16.5 32.1 24.3 32.2 25.3 18.9 
60-69  53.6 40.9  35.4  54.3 39.6 20.1  32.7  22.9 29.3 52.1 43.5 71.9 55.1 23.7 27.6 
70-79  42.0 38.8  25.1  52.3 67.3 23.1  51.9  32.0 19.6 47.1 79.1 107.1  109.1  117.7  83.9 
>80  22.8  15.9  44.3  124.5 228.3 22.1  91.1  461.8 103.1 305.1 485.3 196.0 211.5 160.4 247.8 
Age
a 
95% 
CI 
10.7 
(8.3   -
13.9) 
9.4 
(7.3  - 
12.2) 
7.9 
(5.7  - 
10.9) 
14.8 
(11.7  - 
18.6) 
14.1 
(11.0  - 
18.0) 
4.2 
(2.8  - 
6.2) 
7.7 
(5.7  - 
10.2) 
10.9 
(8.2  - 
14.3) 
6.9 
(4.6  - 
10.2) 
7.5 
(5.7-
9.6) 
7.7 
(6.0-
9.7) 
7.6 
(6.0-
9.5) 
8.2 
(6.5-
10.1) 
6.1 
(4.7-
7.7) 
5.0 
(3.8-
6.5) 
a Rates have been standardized with world standard population 
 
Table 3: Age-specific and -standardized rate/100,000
a of colorectal cancer in Kermanshah Province. 
Age 
(Year) 
1993  1994  1995 1996 1997 1998 1999 2000 2001 2002 2003  2004 2005 2006 2007 
0-39 0.5  0.3  0.1 0.0 0.3 0.2 0.1 0.2 0.2 0.3 0.5  1.2 0.5 1.1 0.5 
40-49  2.0  2.5  1.0 2.6 1.1 1.1 4.1 6.8 4.3 7.4 9.9  10.1  9.7 11.8  17.2 
50-59  4.6  8.4  2.7 5.5 5.7 3.0 15.3  7.8 2.7 13.8  14.0 24.3  30.8  24.1  31.2 
60-69  11.9 26.8 9.9 8.4 6.8 8.0 16.4  8.2 9.8 11.1  24.2 17.6  29.1  23.7  20.3 
70-79 0  14.3  4.1  10.5 6.3  4.6  24.4 35.2 22.9 37.0 61.1  39.7 79.7 56.8 67.1 
>80  17.1  15.9  8.9  26.7 89.3 22.1 15.2 99.0 17.2 89.7 252.3 87.1 70.5 91.6 123.9 
Age
a 
95% 
CI 
3.5 
(2.1-
5.8) 
5.2 
(3.7-
7.6) 
3.1 
(1.9  - 
5.3) 
4.5 
(2.9  - 
6.9) 
4.6 
(2.8  - 
7.2) 
2.0 
(1.0  - 
3.6) 
4.4 
(3.1-
6.4) 
5.8 
(4.1-
8.2) 
2.8 
(1.6  - 
4.9) 
3.6 
(2.5-
5.2) 
6.1 
(4.6-
7.9) 
4.9 
(3.7-
6.4) 
6.0 
(4.6-
7.6) 
5.6 
(4.3-
7.0) 
5.7 
(4.4-
7.1) 
a Rates have been standardized with world standard population. Najafi et al. 
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colorectal cancer belonged to year 2003 when it 
reached 6.1 (95%CI: 4.6-7.9) per 100,000 (Table 3). 
While erratic in terms of the annual incidence, it 
seems that colorectal cancer has an increasing inci-
dence in Kermanshah Province. The average increase 
in annual incidence for colorectal cancer was 0.14 per 
100,000 (95% CI: -0.01-(0.29)) (Table 4). In general, 
the incidence was higher in men with a maximum 
ratio of 2.9 compared to women. Over the 15 years of 
study, the standardized incidence of colorectal cancer 
was 4.5 per 100,000. 
 
Table 4: Annual changes in incidence proportion
Cancer Annual 
changes 
in incidence/ 
100000 
95% confidence 
interval 
Gastric cancer  -0.28  -0.67-0.11 
Esophageal 
cancer 
-0.36 -0.70-(-0.02) 
Colorectal 
cancer 
0.14 -0.01-0.29 
 
 
Discussion 
 
Based on the results of the study, while the figures for 
gastric and esophageal cancers were decreasing the in-
cidence of colorectal cancer was increasing. The de-
creasing incidence of gastric cancer in Kermanshah 
Province seems to be in line with the decrease in the 
incidence and mortality of this cancer in most other 
countries (especially developed countries) which is con-
sidered an important finding.
17,18Although gastric cancer 
was the first cause of cancer related death in the world 
until the mid 90’s; the current mortality of this cancer is 
decreasing albeit more rapidly in developed world.
17,18  
For instance, in Australia, the mortality from gas-
tric cancer decreased from 25.5 per 100,000 in 1950 
to 6.7 per 100,000 in 1994. The highest incidence in 
1996 belonged to Japan (65.0-95.0 per 100,000 in 
men and 27.3-40.1 per 100,000 in women), Korea 
(65.9 and 25.0 per 100,000 in men and women, re-
spectively), and China (46.5 and 21.0 per 100,000 in 
men and women, respectively) and some Latin Amer-
ican countries. In fact, the difference in the incidence 
of gastric cancer among various countries is mainly 
related to the incidence of non-cardiac cancers since 
the incidence of cardiac cancers only varies from 1.5 
to 4.5 per 100,000 around the world.
17,18  
According to an estimation by WHO, the inci-
dence of stomach cancer in Iran (standardized by 
world standard population) was 26.1 and 11.1 per 
100,000 in men and women, respectively in 2002.
19 
However, reports from various geographical areas in 
Iran are different.
20 While northern and northwestern 
Iran are the areas with the highest incidence, Kerman 
in south of Iran has the lowest incidence- around 10.2 
and 5.1 for men and women, respectively.
13 In our 
study, the incidence rate for the last year reached to 
12.1 and 5.5 per 100,000 mark  in men and women, 
respectively which is of course lower than WHO es-
timates and similar to the report from Tehran.
12  
Since, the majority of studies in Iran are limited to a 
hospital or region where they did not calculate the inci-
dence rate, the findings of our study cannot be easily 
compared to them.
5,6,9,10 There are studies that have in-
vestigated the secular trend but they are even more lim-
ited. Using morbidity odds ratios,  Yazdizadeh et al. 
(2007) concluded that the incidence of gastric cancer 
increased in Fars and Tehran provinces during the past 
30 years.
21  The possible explanation for such increase 
might be partly attributed to difference in the method of 
investigating the secular trends and completeness of 
cancer case collection. In addition, two studies investi-
gated the trends in two different time periods.  
The reason for a decreased incidence in gastric 
cancer in Kermanshah may be related to the decrease 
in prevalence of H. pylori infection as well as higher 
consumption of fresh fruits and vegetables.
10,20 Im-
provement in health condition and sanitation as well 
as better treatment have reduced the chance of infec-
tion with H. pylori worldwide.
10,20,22 In addition, more 
effective treatment of other gastrointestinal disorders 
such as reflux, that plays a role in cardiac cancers, can 
contribute to the decrease of incidence of gastric can-
cer. In fact, the 37% increase in population of people 
aged 60 and over (the population at higher risk) in 
Kermanshah Province
14 makes the observed decrease 
even more important.  
Esophageal cancer is reported as the sixth frequent 
cancer in the world.
23 It is characterized by rapid 
growth and high fatality. The decreasing trend in the 
incidence of this cancer is in line with other stud-
ies.
21,23-26  Esophageal cancer is decreasing in most 
areas of the world. However, reports indicate that the 
incidence of squamous cell carcinoma is decreasing 
while adenocarcinoma is increasing.
6,27 As an exam-
ple, while esophageal cancer is an uncommon entity 
in the United States, there has been a 350% increase 
in the incidence of adenocarcinoma between 70’s and 
90’s in men. A similar upward trend has also been 
noticed in many other developed countries.
27  Gastrointestinal tract cancers 
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The highest incidence of esophageal cancer is re-
ported in countries such as China, Mongolia, Ethiopia 
and Iran with the first three countries as high as 28.1 
per 100,000 in.
23 In Iran, the highest incidence is re-
ported in the northern region and in Golestan Prov-
ince (among Turkmen tribe). In Mazandaran and Gui-
lan provinces, only 300 Km to the west, the incidence 
drops sharply.
11 In a recent report from Fars Province 
the incidence of esophageal cancer in people over 15 
was reported at 2.95 per 100,000. The incidence was 
decreased by 64% between 1977 and 1999 of the study 
period.
10 Similarly, in our report the incidence of 
esophageal cancer has significantly decreased over 15 
years and standardized rate with the world population 
was 8.1 per 100,000. These findings are consistence 
with WHO world wide cancer reports but slightly 
higher than recent report from Tehran, Iran.
12,19  
Colorectal cancer is one of the most common ma-
lignancies in the western countries. However, numer-
ous reports from Asia and Latin America indicate that 
its incidence is rising in these countries.
28 Kerman-
shah Province presents the same increasing incidence 
pattern of colorectal cancer reported from other Asian 
and Latin American countries and also from Fars 
Province in south of Iran.
7,27 While developed coun-
tries have high incidence of colorectal cancer, the in-
creasing pattern in countries like Iran is alarming. 
In the report from Fars Province, the age standard-
ized rate for colon cancer among men was 1.61 per 
100,000 during 1970-80 and 4.2 per 100,000 during 
1990-2000 and there was a significant annual increase 
of 0.13 per 100,000 (p>0.05).
7 In Kermanshah, the 
incidence during 15 years of study was 4.5 per 
100,000 with an annual increase of 0.14 per 100,000 
on average. The International Agency for Research on 
Cancer (IRAC) estimates that the incidence of colo-
rectal cancer in Iran will be 8.3 and 6.5 for men and 
women, respectively by 2020. This estimation and 
report from Tehran population-based survey (6.7 and 
4.3/100,000 for colon and rectum, respectively) 
seems to be higher than ours.
12,29,30  Although this 
study was not designed to clearly identify the causes 
of such increase, it can be hypothesized that a change 
toward the western life style and eating unhealthy diet 
may be a major contributing factor.
28   
The current work is one of the few population-
based studies in Iran that addresses the trend in the 
incidence of gastrointestinal cancers. Studies on the 
secular trend of diseases are important in any country 
since they reflect the changes in the epidemiologic 
feature of the disease. These studies are more valua-
ble and more difficult to conduct in developing coun-
tries where cancer registries are not population-based. 
Although the present study does not provide an ideal-
ly accurate image of incidence of gastrointestinal ma-
lignancies, the figures on trends in incidence provide 
valuable information. The major limiting factors that 
may have led to underestimation of the incidence are 
failure in detection of all cases, loss of some of the 
pathology reports, and referring the patients to other 
provinces mainly capital city of Tehran in the initial 
years of the study. Such factors can underestimate 
any decreases in secular trend. Likewise, any increase 
in incidence needs to be interpreted with caution. In 
addition, a well organized population-based cancer 
registry must be completed using other valuable 
sources such as medical and hospital records as well 
as pathology reports and death certificates though 
they are not easily available and linked to cancer reg-
istries in developing countries. Studies like ours may 
not reflect the true incidence for each year. However, 
even in population-based studies where cancer detec-
tion is based on regular and periodic screening pro-
grams, it is still not possible to claim that the true in-
cidence has been calculated. This study is valuable in 
that it was able to report standardized rates and 
trends. Hence it can be compared with similar studies 
from other countries. In order to compare to similar 
reports from elsewhere, we used ICD coding system 
which classifies cancers according to the location of 
organ involvement instead of histology type of ma-
lignancy.
21,24,25 
A decrease in the incidence of gastric and esopha-
geal cancer plus an increase in the incidence of colo-
rectal cancer are all findings that warrant further in-
vestigation. These changes are compatible with an 
epidemiologic transition period where incidence of 
communicable diseases decreases and in turn inci-
dence of the diseases that reflect a change in the life 
style toward a more western model increases. At-
tempts should be made to investigate about contrib-
uting factors to observed trends.  
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